Skip to main content

Study

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

Systematic review of BPC-157 in orthopaedic and sports medicine

Study Credibility: Medium7.2/10Some supporting evidenceStudy has limitationsUse with caution
PublishedJul 2025Last reviewedMar 2026
Email this

Summary

In plain language

This 2025 systematic review looked at whether the experimental compound BPC-157 can help with orthopedic sports injuries. Researchers found that most of the evidence comes from animal studies, with little to no human trial data. The review concluded that while early findings suggest possible benefits for tissue repair and recovery, the lack of strong clinical evidence makes it too early to recommend. For seniors, the potential for joint and tendon healing is promising, but real-world safety and effectiveness remain uncertain.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This systematic review, published in HSS Journal in 2025, examines the emerging interest in the peptide BPC-157 for musculoskeletal and sports-related injuries. The authors evaluated preclinical and limited clinical data, noting that most of the evidence comes from animal studies. They highlight potential mechanisms such as enhanced tendon and ligament healing but caution that translation into human medicine is unproven. The review underscores the lack of randomized controlled trials and advises against premature clinical use until stronger evidence is available.

Research Quality Score

Scored March 23, 2026 using rubric v8_2026-03-10.

Assessment

The study is a systematic review focusing on BPC-157, primarily based on animal studies with limited clinical data. It is methodologically sound in terms of transparency and conflict disclosure but lacks strong empirical evidence due to the absence of RCTs. The relevance to seniors is potential but not directly addressed.

Category Breakdown

CategoryScoreRating
Study design6.7/10
Bias control5.0/10
Statistical methods5.0/10
Reporting completeness10.0/10
Conflicts & funding10.0/10
Replication5.0/10
Relevance to chosen population5.0/10
Journal Reliability10.0/10

Additional Notes

The study highlights the need for more robust clinical trials to establish the efficacy and safety of BPC-157 in humans, particularly for senior populations.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.